Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer - Browder, T; Butterfield, CE; Kraling, BM; Shi, B; Marshall, B; O’Reilly, MS; Folkman, J (Cancer Res, 2000)